Literature DB >> 21135820

Prospects improve for long-lasting flu vaccine.

Elie Dolgin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21135820     DOI： 10.1038/nm1210-1347

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  4 in total

1.  Induction of broadly neutralizing H1N1 influenza antibodies by vaccination.

Authors:  Chih-Jen Wei; Jeffrey C Boyington; Patrick M McTamney; Wing-Pui Kong; Melissa B Pearce; Ling Xu; Hanne Andersen; Srinivas Rao; Terrence M Tumpey; Zhi-Yong Yang; Gary J Nabel
Journal:  Science       Date:  2010-07-15       Impact factor: 47.728

2.  Design of an HA2-based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challenge.

Authors:  Gayathri Bommakanti; Michael P Citron; Robert W Hepler; Cheryl Callahan; Gwendolyn J Heidecker; Tariq Ahmad Najar; Xianghan Lu; Joseph G Joyce; John W Shiver; Danilo R Casimiro; Jan ter Meulen; Xiaoping Liang; Raghavan Varadarajan
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-06       Impact factor: 11.205

3.  Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes.

Authors:  Taia T Wang; Gene S Tan; Rong Hai; Natalie Pica; Lily Ngai; Damian C Ekiert; Ian A Wilson; Adolfo García-Sastre; Thomas M Moran; Peter Palese
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-18       Impact factor: 11.205

4.  Single-dose mucosal immunization with a candidate universal influenza vaccine provides rapid protection from virulent H5N1, H3N2 and H1N1 viruses.

Authors:  Graeme E Price; Mark R Soboleski; Chia-Yun Lo; Julia A Misplon; Mary R Quirion; Katherine V Houser; Melissa B Pearce; Claudia Pappas; Terrence M Tumpey; Suzanne L Epstein
Journal:  PLoS One       Date:  2010-10-04       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.